Klein Peter S
SEC insider (Form 3/4/5 filer). CIK 0001478007. Director at Denali Therapeutics Inc. (DNLI) and 2 other issuers. 6 reported Form 4/5 transactions since Sep 2024; latest on Jun 3, 2026. Located in SOUTH SAN FRANCISCO, CA.
Companies Klein Peter S has filed insider reports for
- Denali Therapeutics Inc. (DNLI): Director
- Accolade, Inc. (ACCD): Director
- F5, INC. (FFIV): Director
Klein Peter S
CIK: 0001478007
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)1 (16.7%)
Derivative conversions
Awards (A)3 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)2 (33.3%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Jun 3, 2026DNLI
Denali Therapeutics Inc.
AwardDirect6.4K shares- - Jun 3, 2025DNLI
Denali Therapeutics Inc.
AwardDirect6K shares- - Apr 8, 2025ACCD
Accolade, Inc.
DispositionDirect28.3K shares at avg. $7.03$199K - Mar 13, 2025FFIV
F5, INC.
AwardDirectRestricted Stock Unit
934 shares- - Mar 12, 2025FFIV
F5, INC.
ExerciseDirect1.3K shares- - Sep 5, 2024FFIV
F5, INC.
GiftDirect1K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 3, 2026 |  DNLI Denali Therapeutics Inc. | Award | 6,408 | - | $0 | Direct |
| Jun 3, 2025 | DNLI Denali Therapeutics Inc. | Award | 6,037 | - | - | Direct |
| Apr 8, 2025 |  ACCD Accolade, Inc. | Disposition | 28,329 | $7.03 | $199,153 | Direct |
| Mar 13, 2025 |  FFIV F5, INC. | Award Restricted Stock Unit | 934 | - | - | Direct |
| Mar 12, 2025 | FFIV F5, INC. | Exercise | 1,309 | - | - | Direct |
| Sep 5, 2024 | FFIV F5, INC. | Gift | 1,000 | - | $0 | Direct |
1-6 of 6 transactions